Lettmann Jason's most recent trade in Alx Oncology Holdings Inc was a trade of 2,382 Common Stock done at an average price of $0.6 . Disclosure was reported to the exchange on Aug. 15, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Alx Oncology Holdings Inc | Jason Lettmann | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 0.64 per share. | 15 Aug 2025 | 2,382 | 212,888 | - | 0.6 | 1,525 | Common Stock |
| Alx Oncology Holdings Inc | Jason Lettmann | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Apr 2025 | 125,000 | 125,000 | - | - | Employee Stock Option (right to buy) | |
| Alx Oncology Holdings Inc | Jason Lettmann | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Mar 2025 | 42,000 | 212,270 | - | 0 | Common Stock | |
| Alx Oncology Holdings Inc | Jason Lettmann | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 1.15 per share. | 19 Feb 2025 | 2,159 | 170,270 | - | 1.2 | 2,483 | Common Stock |
| Alx Oncology Holdings Inc | Jason Lettmann | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jan 2025 | 478,000 | 478,000 | - | - | Employee Stock Option (right to buy) | |
| Alx Oncology Holdings Inc | Lettmann Jason | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Dec 2024 | 200,000 | 200,000 | - | - | Employee Stock Option (right to buy) | |
| Alx Oncology Holdings Inc | Jason Lettmann | Director, CHIEF EXECUTIVE OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.58 per share. | 14 Aug 2024 | 2,191 | 169,429 | - | 2.6 | 5,653 | Common Stock |
| Alx Oncology Holdings Inc | Jason Lettmann | Director, CHIEF EXECUTIVE OFFICER | Purchase of securities on an exchange or from another person at price $ 11.31 per share. | 14 Mar 2024 | 4,400 | 171,620 | - | 11.3 | 49,771 | Common Stock |
| Alx Oncology Holdings Inc | Jason Lettmann | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 190,000 | 190,000 | - | - | Employee Stock Option | |
| Alx Oncology Holdings Inc | Lettmann Jason | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 60,000 | 167,220 | - | 0 | Common Stock | |
| Alx Oncology Holdings Inc | Jason Lettmann | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2023 | 20,200 | 20,200 | - | - | Stock option (right to buy) | |
| Alx Oncology Holdings Inc | Jason Lettmann | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2022 | 12,004 | 12,004 | - | - | Common Stock (right to buy) | |
| Alx Oncology Holdings Inc | Jason Lettmann | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 27.49 per share. | 13 Dec 2021 | 286,496 | 2,101,291 | - | 27.5 | 7,875,775 | Common Stock |
| Alx Oncology Holdings Inc | Jason Lettmann | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 26.48 per share. | 13 Dec 2021 | 17,169 | 2,110,800 | - | 26.5 | 454,635 | Common Stock |
| Alx Oncology Holdings Inc | Jason Lettmann | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 25.29 per share. | 13 Dec 2021 | 11,945 | 2,127,969 | - | 25.3 | 302,089 | Common Stock |
| Alx Oncology Holdings Inc | Jason Lettmann | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 26.48 per share. | 13 Dec 2021 | 2,339 | 287,792 | - | 26.5 | 61,937 | Common Stock |
| Alx Oncology Holdings Inc | Jason Lettmann | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 28.37 per share. | 13 Dec 2021 | 2,196 | 2,099,095 | - | 28.4 | 62,301 | Common Stock |
| Alx Oncology Holdings Inc | Jason Lettmann | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 25.29 per share. | 13 Dec 2021 | 1,627 | 290,131 | - | 25.3 | 41,147 | Common Stock |
| Alx Oncology Holdings Inc | Jason Lettmann | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 29.60 per share. | 13 Dec 2021 | 1,329 | 2,097,766 | - | 29.6 | 39,338 | Common Stock |
| Alx Oncology Holdings Inc | Jason Lettmann | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 27.49 per share. | 13 Dec 2021 | 1,296 | 286,496 | - | 27.5 | 35,627 | Common Stock |
| Alx Oncology Holdings Inc | Jason Lettmann | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 30.23 per share. | 13 Dec 2021 | 440 | 2,097,326 | - | 30.2 | 13,301 | Common Stock |
| Alx Oncology Holdings Inc | Jason Lettmann | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 28.37 per share. | 13 Dec 2021 | 299 | 286,197 | - | 28.4 | 8,483 | Common Stock |
| Alx Oncology Holdings Inc | Jason Lettmann | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 29.60 per share. | 13 Dec 2021 | 181 | 286,016 | - | 29.6 | 5,358 | Common Stock |
| Alx Oncology Holdings Inc | Jason Lettmann | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 30.23 per share. | 13 Dec 2021 | 60 | 285,956 | - | 30.2 | 1,814 | Common Stock |
| Alx Oncology Holdings Inc | Jason Lettmann | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2021 | 12,004 | 12,004 | - | - | Stock Option (right to buy) |